Journals / Archives of epilepsy (Online) / 2022 / Cilt: 28 - Sayı: 1

Investigation of the Effects of Antiepileptics On Mitotic Proliferation in Glioblastoma and Neuroblastoma in Vitro Cell Cultures

Pages
1–7
Publication Date
2022-10-12
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In in vitro neuroblastoma cell cultures, it was found that only valproic acid and zonisamide had antimitotic effects, and other drugs studied did not have antimitotic effects.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: The frequency of epileptic seizures is high in patients with brain tumors and its treatment is important.
📊
Key Findings & Data:Methods: In our study, anti-tumoral activities of antiepileptic agents containing gabapentin, pregabalin, valproic acid, levetiracetam, zonisamide, phenytoin, carbamazepine in in vitro glioblastoma (c6) and neuroblastoma cell cultures (NA/An1) were evaluated with a real-time cell analysis system.
💡
Conclusion & Impact:In in vitro neuroblastoma cell cultures, it was found that only valproic acid and zonisamide had antimitotic effects, and other drugs studied did not have antimitotic effects.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: The frequency of epileptic seizures is high in patients with brain tumors and its treatment is important. It is atypical mitotic proliferation that is effec- tive in the proliferation of malignant tumor cells. It is known that antiepileptics have direct or indirect effects on mitotic proliferation. In our study, we aimed to maximize the use of both the antiepileptic effect and the cytoreductive effect by suppressing tumor growth while choosing the drug to stop the seizure. Methods: In our study, anti-tumoral activities of antiepileptic agents containing gabapentin, pregabalin, valproic acid, levetiracetam, zonisamide, phenytoin, carbamazepine in in vitro glioblastoma (c6) and neuroblastoma cell cultures (NA/An1) were evaluated with a real-time cell analysis system. Statistically, the difference between groups was investigated by analysis of variance, followed by post hoc Tukey’s test Statistical Package for the Social Sciences software 16.0 (IBM Inc, Chicago, IL, USA). Results: In our study, it was observed that all drugs except gabapentin had antimitotic effects in glioblastoma cell cultures, among which phenytoin, levetirace- tam, and valproic acid had dose-dependent antimitotic effects, while carbamazepine had reduced antimitotic effects at concentrations above 25 μg/mL. In in vitro neuroblastoma cell cultures, it was found that only valproic acid and zonisamide had antimitotic effects, and other drugs studied did not have antimitotic effects. Conclusions: In our study, it was observed that the preference of antiepileptics with a high antimitotic effect on tumoral cells was important when arranging seizure treatment in patients with brain tumors

🔖

Cite This Article

Altun, A., Güneri, M. C., Bolayır, E., Güneri, Ş. Ç. (2022). Investigation of the Effects of Antiepileptics On Mitotic Proliferation in Glioblastoma and Neuroblastoma in Vitro Cell Cultures. Archives of epilepsy (Online), Cilt: 28 - Sayı: 1, 1–7. https://ajindex.com/articles/447848

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (1)

  1. Van Breemen MS, Wilms EB, Vecht CJ. Epilepsy in patients with brain tumours: epidemiology, mechanisms, and management. Lancet Neurol. 2007;6(5):421-430. [CrossRef] 2. İbrahim B. Epilepsi. Istanbul: Nobel Tip Kitabevi; 2008:593-609. 3. Martín JMP, Freire PF, Labrador V, Hazen MJ. Carbamazepine induces mitotic arrest in mammalian Vero cells. Mutat Res. 2008;637(1-2):124- 133. [CrossRef] 4. Dethloff L, Barr B, Bestervelt L, et al. Gabapentin-induced mitogenic activity in rat pancreatic acinar cells. Toxicol Sci. 2000;55(1):52-59. [CrossRef] 5. Blaheta RA, Cinatl J. Anti-tumor mechanisms of valproate: a novel role for an old drug. Med Res Rev. 2002;22(5):492-511. [CrossRef] 6. Schinkel AH, Wagenaar E, Mol CA, van Deemter L. P-glycoprotein in the blood-brain barrier of mice influences the brain penetration and phar- macological activity of many drugs. J Clin Invest. 1996;97(11):2517- 2524. [CrossRef] 7. Owen A, Pirmohamed M, Tettey JN, Morgan P, Chadwick D, Park BK. Carbamazepine is not a substrate for P-glycoprotein.Br J Clin Pharmacol. 2001;51(4):345-349. [CrossRef] 8. Weiss J, Kerpen CJ, Lindenmaier H, Dormann SM, Haefeli WE. Interac- tion of antiepileptic drugs with human P-glycoprotein in vitro. J Phar- macol Exp Ther. 2003;307(1):262-267. [CrossRef] 9. Ryu CH, Park KY, Kim SM, et al. Valproic acid enhances anti-tumor effect of mesenchymal stem cell mediated HSV-TK gene therapy in intracranial glioma. Biochem Biophys Res Commun. 2012;421(3):585- 590. [CrossRef] 10. Chlenski A, Liu S, Crawford SE, et al. SPARC is a key Schwannian- derived inhibitor controlling neuroblastoma tumor angiogenesis. Cancer Res. 2002;62(24):7357-7363. 11. Yang Q, Tian Y, Liu S, et al. Thrombospondin-1 peptide ABT-510 com- bined with valproic acid is an effective antiangiogenesis strategy in neu- roblastoma. Cancer Res. 2007;67(4):1716-1724. [CrossRef] 12. Blaheta RA, Michaelis M, Driever PH, Cinatl J. Evolving anticancer drug valproic acid: insights into the mechanism and clinical studies. Med Res Rev. 2005;25(4):383-397. [CrossRef] 13. Cinatl JJ, Cinatl J, Driever PH, et al. Sodium valproate inhibits in vivo growth of human neuroblastoma cells. Anticancer Drugs. 1997;8(10):958- 963. [CrossRef] 14. Cinatl J, Kotchetkov R, Blaheta R, Driever PH, Vogel JU, Cinatl J. Induc- tion of differentiation and suppression of malignant phenotype of human neuroblastoma BE (2)-C cells by valproic acid: enhancement by combi- nation with interferon-alpha. Int J Oncol. 2002;20(1):97-106. 15. Mo